| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $80,707,584 ) (Continued on the next page) |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01NS131319 | Understanding the role of SCN8A in developmental and epileptic encephalopathy | 000 | 2 | NIH | 1/17/2025 | $336,586 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R00HL157684 | Regulation of STAT3 phosphorylation and its role in orienting myocyte hypertrophy | 000 | 4 | NIH | 4/18/2025 | $249,000 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA270372 | Chemotherapy-induced circadian master clock disruptions and fatigue | 001 | 3 | NIH | 12/5/2024 | $72,094 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA270372 | Chemotherapy-induced circadian master clock disruptions and fatigue | 000 | 3 | NIH | 12/3/2024 | $476,377 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01AR079485 | Novel non-viral reprogramming strategies to treat Discogenic back pain via engineered extracellular vesicles | 000 | 4 | NIH | 1/23/2025 | $446,823 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R25NS120282 | Explorations in Neuroscience Research For High School Students | 000 | 5 | NIH | 11/19/2024 | $82,861 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA248739 | A Randomized Controlled Trial: Genetic Counseling Patient Preference Intervention via Electronic Health Record Portal vs. Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer | 000 | 5 | NIH | 12/19/2024 | $474,811 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01DK127444 | Receptor-mediated glucose sensing and skeletal muscle function | 000 | 5 | NIH | 12/18/2024 | $351,000 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K08DE033142 | Nanotransfection-based Cell Reprogramming to Drive Bone Revascularization in a Novel Mouse Model of Autogenous Cranioplasty | 000 | 2 | NIH | 4/18/2025 | $163,620 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01NS124681 | Mechanisms of mineralocorticoid receptor antagonism on inflammation in muscular dystrophy | 000 | 4 | NIH | 12/23/2024 | $416,142 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01AI148180 | The role of Bik in the replication and severity of influenza A virus | 000 | 6 | NIH | 12/19/2024 | $396,208 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01AG082044 | Integrating eSAGE with EHR data using machine learning for the early detection and monitoring of cognitive impairment in individuals including those underserved | 000 | 2 | NIH | 3/21/2025 | $678,653 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH134402 | Target Host Epigenetic Regulation of HIV Proviruses to Reinforce Viral Deep Latency in Microglia | 000 | 3 | NIH | 4/16/2025 | $577,723 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HD110503 | Prenatal Immunomonitoring in Spontaneous Preterm Birth Prevention (PROMIS) | 001 | 2 | NIH | 4/28/2025 | $47,707 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HD110503 | Prenatal Immunomonitoring in Spontaneous Preterm Birth Prevention (PROMIS) | 000 | 2 | NIH | 1/13/2025 | $429,370 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH131606 | Neural and Behavioral Mechanisms of Angry Hostility in Depression | 000 | 3 | NIH | 3/28/2025 | $641,592 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01DK137431 | Next generation of AAV vector targeting adipose tissue | 000 | 2 | NIH | 4/17/2025 | $487,463 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R61AG081982 | Development of an online mindfulness training program for adults with subjective cognitive decline | 001 | 2 | NIH | 4/25/2025 | $464,114 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA270251 | A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL | 000 | 3 | NIH | 11/14/2024 | $409,798 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL165751 | Distinct Ion Channel Pools and Intercalated Disk Nanoscale Structure Regulate Cardiac Conduction | 000 | 3 | NIH | 1/27/2025 | $663,775 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA276222 | Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial | 000 | 3 | NIH | 1/24/2025 | $481,412 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K08DC020761 | Engineering protease biomarkers to guide surgical therapy for vestibular schwannoma and Neurofibromatosis Type 2 | 000 | 3 | NIH | 12/18/2024 | $184,001 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA269984 | Targeting GPR84 to Overcome Macrophage Mediated Resistance to Immunotherapy | 000 | 3 | NIH | 3/11/2025 | $324,627 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA286017 | ROLES AND MECHANISMS OF TERTIARY LYMPHOID STRUCTURES IN ANTI-TUMOR IMMUNITY | 000 | 2 | NIH | 12/2/2024 | $383,293 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01DK133859 | Engineering the release of oxylipins through the skin | 000 | 3 | NIH | 4/29/2025 | $641,396 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R25TW012217 | UoN-OSU MSc in One Health and Emergency Research Ethics (MOHERE) | 000 | 4 | NIH | 3/12/2025 | $242,169 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA279965 | Endoscopic Ultrasound-guided In Vivo Confocal Laser Endomicroscopy as an Imaging Biomarker for the Accurate Risk Stratification of Intraductal Papillary Mucinous Neoplasms | 000 | 3 | NIH | 3/10/2025 | $394,895 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R00AT011374 | Human gut bacterial cell surface polysaccharides as a microbial nutrient source and target of immunoregulatory proteins shape gut microbiota structure and function | 000 | 5 | NIH | 4/17/2025 | $215,520 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA248741 | Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer | 000 | 5 | NIH | 2/17/2025 | $667,657 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL168045 | Therapeutic Strategies to Mitigate Toxicities of Anthracycline-Based Therapeutics | 000 | 2 | NIH | 12/6/2024 | $671,704 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH133925 | Inflammatory Challenge in Human Aggression | 000 | 1 | NIH | 2/14/2025 | $65,363 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH133925 | Inflammatory Challenge in Human Aggression | 001 | 2 | NIH | 3/27/2025 | $38,490 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH133925 | Inflammatory Challenge in Human Aggression | 001 | 2 | NIH | 3/27/2025 | $638,721 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03CA286694 | Mechanisms of Resistance and Therapeutic Targets in T-LGL Leukemia | 000 | 2 | NIH | 12/3/2024 | $78,750 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA249198 | Targeting cholesterol metabolism and replication stress response in cancer therapy | 000 | 5 | NIH | 1/3/2025 | $321,165 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01LM014385 | Generative AI for retrosynthesis libraries | 000 | 2 | NIH | 12/3/2024 | $297,004 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01AI173072 | Overcoming Resistance to Novel Bacterial Topoisomerase Inhibitors | 000 | 3 | NIH | 11/19/2024 | $590,675 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R37CA248371 | Energy Balance, mTOR pathway signaling, and breast cancer prognosis | 000 | 6 | NIH | 1/9/2025 | $644,581 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01LM013879 | Penalized mixture cure models for identifying genomic features associated with outcome in acute myeloid leukemia | 000 | 4 | NIH | 12/13/2024 | $232,382 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01GM149080 | Integrating Accelerated Droplet Chemistry with LC-MS for High Throughput Quantitative Analysis | 000 | 3 | NIH | 12/19/2024 | $275,697 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA287261 | Fecal microbial transplantation for chemotherapy behavioral side effects | 000 | 2 | NIH | 1/16/2025 | $541,528 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03CA280007 | A sensitivity analysis framework for generalizing randomized clinical trial results in the presence of unmeasured treatment effect modifiers | 000 | 2 | NIH | 11/26/2024 | $80,739 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21AI180862 | Redox Regulation of Sarcoidosis Granulomas and Fibrosis | 000 | 2 | NIH | 4/28/2025 | $236,250 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R35GM151095 | Gene positioning and dynamic chromatin organization of the human genome | 000 | 3 | NIH | 5/2/2025 | $382,636 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R34EY035783 | Identification of School-age Eye conditions Evaluation (ISEE) | 000 | 2 | NIH | 3/28/2025 | $236,650 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R37CA259642 | Time-varying relationships between built environment factors, colon and rectum cancer prognosis, and survival | 000 | 4 | NIH | 4/16/2025 | $501,450 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH135117 | Progression of Social Cognitive Deficits in Mid- and Late-Life Schizophrenia Spectrum Disorders | 000 | 2 | NIH | 1/14/2025 | $752,698 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA278052 | Addressing Disparities in Outcomes of Screening for Colorectal Cancer in Community-Based Settings | 000 | 3 | NIH | 4/14/2025 | $604,360 |
| 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01NS130308 | Mechanisms underlying regulation of injured axons in CNS autoimmunity | 000 | 2 | NIH | 11/20/2024 | $469,016 |
|